| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeOne Medicines Ltd. | Global Head of R&D | Ordinary Shares | 1.02M | $315M | $307.51 | Sep 9, 2025 | Direct |
| BeOne Medicines Ltd. | Global Head of R&D | Ordinary Shares | 602K | $185M | $307.51 | Sep 9, 2025 | Indirect |
| BeOne Medicines Ltd. | Global Head of R&D | American Depositary Shares | 0 | $0 | $260.00 | Jun 23, 2025 | Direct |
| BeOne Medicines Ltd. | Global Head of R&D | American Depositary Shares | 0 | $0 | $350.06 | Sep 9, 2025 | Indirect |
| BeOne Medicines Ltd. | Global Head of R&D | Share Option (Right to Buy) | 163K | Jun 10, 2025 | Direct | ||
| BeOne Medicines Ltd. | Global Head of R&D | RMB Shares | 0 | Sep 9, 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | Sep 9, 2025 | 1 | -$1.75M | 4 | Sep 11, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jul 29, 2025 | 4 | -$1.3M | 4 | Jul 31, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jul 18, 2025 | 1 | -$210K | 4 | Jul 22, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jun 23, 2025 | 1 | -$267K | 4 | Jun 25, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jun 16, 2025 | 2 | -$432K | 4 | Jun 18, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jun 10, 2025 | 2 | $0 | 4 | Jun 12, 2025 | Global Head of R&D |
| ONC | BeOne Medicines Ltd. | Jun 6, 2025 | 4 | -$354K | 4 | Jun 10, 2025 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Mar 5, 2025 | 1 | $0 | 4 | Mar 7, 2025 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Feb 21, 2025 | 6 | -$1.29M | 4 | Feb 25, 2025 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Sep 27, 2024 | 1 | -$1.1M | 4 | Oct 1, 2024 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 24, 2024 | 2 | -$170K | 4 | Jun 26, 2024 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 17, 2024 | 5 | -$368K | 4 | Jun 20, 2024 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 26, 2023 | 2 | -$202K | 4 | Jun 27, 2023 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 15, 2023 | 3 | -$255K | 4 | Jun 20, 2023 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 7, 2023 | 4 | -$104K | 4 | Jun 9, 2023 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 27, 2022 | 1 | -$81.2K | 4 | Jun 28, 2022 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 17, 2022 | 2 | -$170K | 4 | Jun 22, 2022 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 6, 2022 | 1 | -$93.7K | 4 | Jun 8, 2022 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | May 17, 2022 | 4 | $4.03M | 4 | May 19, 2022 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Dec 15, 2021 | 4 | $0 | 4 | Dec 17, 2021 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 28, 2021 | 1 | -$165K | 4 | Jun 30, 2021 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 16, 2021 | 3 | -$266K | 4 | Jun 21, 2021 | Global Head of R&D |
| BGNE | BeiGene, Ltd. | Jun 7, 2021 | 1 | -$232K | 4 | Jun 9, 2021 | Global Head of R&D |